CoChat

Helios Should Not Be Cited as a Marker of Human Thymus-Derived Tregs. Commentary: Helios+ and Helios− Cells Coexist within the Natural FOXP3+ T Regulatory Cell Subset in Humans

Open access
Elkord, Eyad · 2016 · Frontiers in Immunology
Cited by 60

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

A commentary on Helios+ and Helios− Cells Coexist within the Natural FOXP3+ T Regulatory Cell Subset in Humans by Himmel ME, MacDonald KG, Garcia RV, Steiner TS, Levings MK. J Immunol (2013) 190:2001–8. doi: 10.4049/jimmunol.1390018 Thymus-derived Tregs (tTregs) mediate peripheral tolerance, which benefits the host by controlling inflammation and preventing autoimmunity, whereas peripherally induced Tregs (pTregs) mediate tumor-induced suppression, which hurts the host by suppressing beneficial anti-tumor immunity (1–4). In 2010, Dr. Shevach’s group reported that Helios expression discriminates tTregs from pTregs (5). This work generated a lot of excitement due to the real need for markers to discriminate the good tTregs from the bad pTregs. This is of particular importance to specifically target pTregs to enhance anti-tumor immunity, while reserving tTregs to avoid provoking autoimmune diseases. Soon after, this work was questioned, and several studies showed that Helios can be induced in Foxp3+ T cells (6). A great wealth of recent studies excludes the value of Helios as a marker of tTregs. For example, a strong Helios expression can be induced in pTregs (7), and Helios expression is a marker of T cell activation and proliferation (8). Furthermore, it was confirmed that both Helios+/− subsets coexist within human FoxP3+ tTreg (9). A more recent study showed that neither Helios nor Neuropilin-1 expressions could identify Tregs of thymic or peripheral origin (10). Regarding Helios function, Helios regulates Treg functional stability by inducing epigenetic silencing of IL-2 expression, and loss of Helios expression in Tregs enhanced expression of the IL-2 gene resulting in increased Treg proliferation and secretion of IL-2 following activation, as well as impaired suppressive activity (11). A more recent study by Dr. Shevach’s group reported that Helios controls some aspects of Treg-suppressive function (12). Interestingly, impairing Helios expression in Foxp3+ Tregs results in defective Tregs, and Helios is required for their stable inhibitory activity (13). Additionally, we found that Helios, and not FoxP3, is the marker of activated Tregs expressing immunosuppressive markers GARP/LAP (14). Taken together, Helios expression confers stable phenotype of Tregs, and FoxP3+Helios+ Tregs have enhanced immunosuppressive characteristics, compared with FoxP3+Helios− Tregs (8, 15). Despite all these several recent studies confirmed that Helios is not a tTreg marker, unfortunately many studies cited/are still citing Helios as a tTreg marker. I believe that it is of great importance to make this very clear to avoid further confusion to the scientific community and not to cite Helios as a marker of tTregs anymore. Other Information Published in: Frontiers in Immunology License: https://creativecommons.org/licenses/by/4.0/ See article on publisher's website: https://dx.doi.org/10.3389/fimmu.2016.00276

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fimmu.2016.00276

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 60

Metadata

Authors
Elkord, E.
Venue
Frontiers in Immunology
Published
2016-07-08
Volume
7
Pages
276-276
ISSN
1664-3224 (ISSN-L)
OpenAlex
W2460256823
Cited by
60
References
7
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.